title: Characterization of the interferon genes in homozygous rainbow trout reveals two novel genes, alternate splicing and differential regulation of duplicated genes.
abstract: The genes encoding the type I and type II interferons (IFNs) have previously been identified in rainbow trout and their proteins partially characterized. These previous studies reported a single type II IFN (rtIFN-gamma) and three rainbow trout type I IFN genes that are classified into either group I (rtIFN1, rtIFN2) or group II (rtIFN3). In this present study, we report the identification of a novel IFN-gamma gene (rtIFN-gamma2) and a novel type I group II IFN (rtIFN4) in homozygous rainbow trout and predict that additional IFN genes or pseudogenes exist in the rainbow trout genome. Additionally, we provide evidence that short and long forms of rtIFN1 are actively and differentially transcribed in homozygous trout, and likely arose due to alternate splicing of the first exon. Quantitative reverse transcriptase PCR (qRT-PCR) assays were developed to systematically profile all of the rainbow trout IFN transcripts, with high specificity at an individual gene level, in naïve fish and after stimulation with virus or viral-related molecules. Cloned PCR products were used to ensure the specificity of the qRT-PCR assays and as absolute standards to assess transcript abundance of each gene. All IFN genes were modulated in response to Infectious hematopoietic necrosis virus (IHNV), a DNA vaccine based on the IHNV glycoprotein, and poly I:C. The most inducible of the type I IFN genes, by all stimuli tested, were rtIFN3 and the short transcript form of rtIFN1. Gene expression of rtIFN-gamma1 and rtIFN-gamma2 was highly up-regulated by IHNV infection and DNA vaccination but rtIFN-gamma2 was induced to a greater magnitude. The specificity of the qRT-PCR assays reported here will be useful for future studies aimed at identifying which cells produce IFNs at early time points after infection.
authors.affiliation: US Geological Survey, Western Fisheries Research Center, 6505 NE 65th St., Seattle, WA 98034, USA. mpurcell@usgs.gov
authors.forename: Maureen K
authors.initials: MK
authors.lastname: Purcell
authors.forename: Kerry J
authors.initials: KJ
authors.lastname: Laing
authors.forename: James C
authors.initials: JC
authors.lastname: Woodson
authors.forename: Gary H
authors.initials: GH
authors.lastname: Thorgaard
authors.forename: John D
authors.initials: JD
authors.lastname: Hansen
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D017398:Alternative Splicing; D000595:Amino Acid Sequence; D000818:Animals; D005393:Fish Diseases / Q000276:immunology; D020440:Gene Duplication; D005786:Gene Expression Regulation / Q000187:drug effects; D029142:Infectious hematopoietic necrosis virus / Q000276:immunology; D007372:Interferons / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D008969:Molecular Sequence Data; D017686:Oncorhynchus mykiss / Q000235:genetics* / Q000276:immunology*; D011070:Poly I-C / Q000494:pharmacology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018353:Rhabdoviridae Infections / Q000276:immunology / Q000662:veterinary; D016415:Sequence Alignment; D017422:Sequence Analysis, DNA; D017386:Sequence Homology, Amino Acid; D019444:Vaccines, DNA / Q000494:pharmacology; D014765:Viral Vaccines / Q000494:pharmacology
chemical_list: D000276:Adjuvants, Immunologic; D019444:Vaccines, DNA; D014765:Viral Vaccines; D007372:Interferons; D011070:Poly I-C